Effects of IL-3 gene expression on tumor response to irradiation in vitro and in vivo

Cancer Research

Volumn 57, Issue 18, 1997, Pages 3899-3903

  Chiang, Chi Shiun ^a   Syljuäsen, Randi G ^b   Hong, Ji Hong ^c   Wallis, Anne ^d   Dougherty, Graeme J ^b   McBride, William H ^b  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 3;

ANIMAL CELL; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; DOSE RESPONSE; DRUG EFFECT; FIBROSARCOMA; GENE EXPRESSION; GROWTH INHIBITION; IMMUNE RESPONSE; IMMUNOGENICITY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; ANTIGENS, CD44; CELL SURVIVAL; FEMALE; FIBROSARCOMA; GENE EXPRESSION; GRANULOCYTES; H-2 ANTIGENS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-3; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGES; MICE; MICE, INBRED C3H; SARCOMA, EXPERIMENTAL; TRANSDUCTION, GENETIC;

EID: 1842376251     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Seung, L. P., Mauceri, H. J., Beckett, M. A., Hallahan, D. E., Hellman, S., and Weichselbaum, R. R. Genetic radiotherapy overcomes tumor resistance to cytotoxic agents. Cancer Res., 55: 5561-5565, 1995.
2. Mauceri, H. J., Hanna, N. N., Wayne, J. D., Hallahan, D. E., Hellman, S., and Weichselbaum, R. R. Tumor necrosis factor α (TNF-α) gene therapy targeted by ionizing. Cancer Res., 56: 4311-4314, 1996.
3. Gallardo, D., Drazan, K. E., and McBride, W. H. Adenovirus-based transfer of wild-type p53 gene increases ovarian tumor. Cancer Res., 56: 4891-4893, 1996.
4. Hamada, M., Fujiwara, T., Hizuta, A., Gochi, A., Naomoto, Y., Takakura, N., Takahashi, K., Roth, J. A., Tanaka, N., and Orita, K. The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers. J. Cancer Res. Clin. Oncol., 122: 360-365, 1996.
5. Rogulski, K. R., Kim, J. H., Kim, S. H., and Freytag, S. O. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene. Hum. Gene Ther., 8: 73-85, 1997.
6. McBride, W. H., Economou, J. S., Kuber, N., Hong, J. H., Chiang, C. S., Syljuäsen, R., Dougherty, S. T., and Dougherty, G. J. Modification of tumor microenvironment by cytokine gene transfer. Acta Oncol., 34: 447-451, 1995.
7. McBride, W. H., Dougherty, G. D., Wallis, A. E., Economou, J. S., and Chiang, C. S. Interleukin-3 in gene therapy of cancer. Folia Biol. (Warsaw), 40: 62-73, 1993.
8. McBride, W. H., Thacker, J. D., Comora, S., Economou, J. S., Kelley, D., Hogge, D., Dubinett, S. M., and Dougherty, G. J. Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity. Cancer Res., 52: 3931-3937, 1992.
9. Levitsky, J. W., Simons, H., Vogelstein, B., and Frost, P. Interleukin-2 production by tumor cell bypasses T helper function in the generation of an antitumor response. Cell, 60: 397-403, 1990.
10. Tepper, R. I., Pattengale, P. K., and Leder, P. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell. 57: 503-515, 1989.
11. Asher, A. L., Mule, J. J., Kasid, A., Restifo, N. P., Salo, J. C., Reichert, C. M., Jaffe, G., Fendly, B., Kreigler, M., and Rosenberg, S. Murine tumor cells transduced with the gene for tumor necrosis factor-α: evidence for a paracrine immune effect of tumor necrosis factor against tumors. J. Immunol., 146: 3227-3234, 1991.
12. Colombo, M. P., Ferrari, G., Stoppacciaro, A., Parenza, M., Rodolfo, M., Mavilio, F., and Parmiani, G. Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo. J. Exp. Med., 173: 889-897, 1991.
13. Orkin, S. H. Report and recommendations of the panel to assess the NIH investment in research on gene therapy. NIH Rep., pp. 1-48, Dec. 9, 1995.
14. Pulaski, B. A., McAdam, A. J., Hutter, E. K., Biggar, S., Lord, E. M., and Frelinger, J. G. Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism. Cancer Res., 53: 2112-2117, 1993.
15. Hobbs, M. V., Weigle, W. O., Noonan, D. J., Torbett, B. E., McEvilly, R. J., Koch, R. J., Cardenas, G. J., and Ernst, D. N. Patterns of cytokine gene expression by CD4+ T cells from young and old mice. J. Immunol., 150: 3602-3608, 1993.
16. Milas, L., Furuta, U., Hunter, N., Nishiguchi, I., and Runkel, S. Dependence of indomethacin-induced potentiation of murine tumor radioresponse on tumor host immunocompetence. Cancer Res., 50: 4473-4477, 1990.
17. Frendl, G., and Beller, D. I. Regulation of macrophage activation by IL-3. I. IL-3 functions as a macrophage-activating factor with unique properties, including Ia and lymphocyte function-associated antigen-I but not cytotoxicity. J. Immunol., 144: 3392-3399, 1990.
18. Caux, C., Vandervliet, B., Massacrier, C., Durand, I., and Banchereau, J. Interleukin-3 cooperates with tumor necrosis factor a for the development of human dendritic/Langerhans cells from cord blood CD34+ hematopoietic progenitor cells. Blood, 87: 2376-2385, 1996.
19. Cameron, R. B., Spiess, P. J., and Rosenberg, S. A. Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. J. Exp. Med., 171: 249-263, 1990.